Skip Navigation


European Heart Journal Advance Access originally published online on August 25, 2005
European Heart Journal 2005 26(21):2344; doi:10.1093/eurheartj/ehi465
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/21/2344    most recent
ehi465v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Borja, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borja, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Ezetimibe coadministered with fenofibrate: some safety questions

Javier Borja

J. Uriach y Compañía, S.A.
Polígon Industrial Riera de Caldes
Avinguda Camí Reial, 51-57
Palau-solità i Plegamans
08184 Barcelona
Spain
Tel: +34 902 471 511
Fax: +34 938 646 606
E-mail address: fv-borja@uriach.com

The first 10% of the full text of this article appears below.

I would like to comment on some questions in reference to the article of Dr Farnier and co-workers on the coadministration of ezetimibe with fenofibrate in patients with mixed . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
C. D Meyers, Y. S. Moon, H. Ghanem, and N. D Wong
Type Of Preexisting Lipid Therapy Predicts LDL-C Response to Ezetimibe
Ann. Pharmacother., May 1, 2006; 40(5): 818 - 823.
[Abstract] [Full Text] [PDF]